SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

100.5174369

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

42.63

42421.81

EPS(TTM)

Face Value()

Div & Yield %

58.74

2.16

Back

ultratech cement ltd

Rallis India standalone net profit declines 81.82% in the December 2025 quarter

Jan 21,2026

Net profit of Rallis India declined 81.82% to Rs 2.00 crore in the quarter ended December 2025 as against Rs 11.00 crore during the previous quarter ended December 2024. Sales rose 19.35% to Rs 623.00 crore in the quarter ended December 2025 as against Rs 522.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	623.00	522.00	19
OPM %	9.31	8.43	-
PBDT	65.00	48.00	35
PBT	36.00	19.00	89
NP	2.00	11.00	-82

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,300.41 -53.36 (-0.52%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)